Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.033 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |